✦ LIBER ✦

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

✍ Scribed by Dagley, Laura F.; Emili, Andrew; Purcell, Anthony W.

Book ID: 118766195
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 706 KB
Volume: 7
Category: Article
ISSN: 1862-8346
DOI: 10.1002/prca.201200104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteomics technologies for biomarker di

Proteomics technologies for biomarker discovery in multiple sclerosis

✍ Vaibhav Singh; Rogier Q. Hintzen; Theo M. Luider; Marcel P. Stoop 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Novel technologies for the discovery and

Novel technologies for the discovery and quantitation of biomarkers of toxicity

✍ Fitz B. Collings; Vishal S. Vaidya 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Proteomic Approaches to the Discovery of

Proteomic Approaches to the Discovery of Cancer Biomarkers for Early Detection and Personalized Medicine

✍ Honda, K.; Ono, M.; Shitashige, M.; Masuda, M.; Kamita, M.; Miura, N.; Yamada, T 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 217 KB

Application of mass spectrometry to the

Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer

✍ O. John Semmes; Gunjan Malik; Mike Ward 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

## Abstract There has been an impressive emergence of mass spectrometry based technologies applied toward the study of proteins. Equally notable is the rapid adaptation of these technologies to biomedical approaches in the realm of clinical proteomics. Concerted efforts toward the elucidation of th

Discovery of fingolimod, the sphingosine

Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis

✍ Chiba, Kenji; Adachi, Kunitomo 📂 Article 📅 2012 🏛 Future Science 🌐 English ⚖ 956 KB

Strategies for the application of functi

Strategies for the application of functional genomics technology to biopharmaceutical drug discovery

✍ Pennina R. Langer-Safer; Lori J. Fitz; Maryann Z. Whitley; Clive R. Wood; David 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 2 views

We have developed a strategy to apply genomics and functional genomics-based technologies to the discovery of novel proteins which represent potential therapeutic candidates. The core of this strategy is based on a process for the high-throughput discovery, full-length cDNA cloning and expression of